Publications by authors named "Michelle Rath"

Claim this Profile
C
Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients.
Michelle Rath, Qiyuan Li, Huili Li, Sara Lindström, Alexander Miron

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
Michelle Rath, Qiyuan Li, Huili Li, Sara Lindström, Alexander Miron

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trial.
Entcho Klenske, Steffen Zopf, Clemens Neufert, Andreas Nägel, Jürgen Siebler, Michelle G Rath, Markus F Neurath, Timo Rath

PLoS One· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12).
André Hennigs, Jörg Heil, Annette Wagner, Michelle Rath, Helfried Moosbrugger

Breast· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncotype DX in breast cancer patients: clinical experience, outcome and follow-up-a case-control study.
Michelle G Rath, Lorenz Uhlmann, Marita Fiedler, Joerg Heil, Michael Golatta

Arch Gynecol Obstet· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Residual Tumor in Breast-Conserving Therapy.
Michelle G Rath, Lorenz Uhlmann, Joerg Heil, Christoph Domschke, Zdravka Roth

Ann Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk.
Alina Anton, Sarah Schott, Gisela Kaip, Michelle Rath, Jörg Heil

Arch Gynecol Obstet· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
Michelle G Rath, Serena Masciari, Rebecca Gelman, Alexander Miron, Penelope Miron

Breast Cancer Res Treat· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs in plasma as early detection markers for breast cancer.
Katarina Cuk, Manuela Zucknick, Jörg Heil, Dharanija Madhavan, Sarah Schott, Michelle Rath

Int J Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of resectability in breast-conserving therapy.
Michelle G Rath, Joerg Heil, Christoph Domschke, Zdravka Topic, Sven Schneider

Arch Gynecol Obstet· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene.
Michelle G Rath, Farnoosh Fathali-Zadeh, Anne Langheinz, Sandrine Tchatchou, Theda Voigtländer

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis